H35.319
Nonexudative age-related macular degeneration, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Nonexudative age-related macular degeneration (AMD), also known as dry AMD, is a common eye condition that primarily affects older adults. It involves the gradual deterioration of the central part of the retina called the macula, which is responsible for sharp, straight-ahead vision. When this deterioration occurs without the presence of fluid leakage or bleeding, it is classified as nonexudative or dry AMD. This condition can lead to gradual vision loss, impacting daily activities such as reading and recognizing faces. Although there is currently no cure for dry AMD, early detection and management can help slow its progression and preserve vision as long as possible.
Causes & Symptoms
Clinical Causes: Aging: The primary risk factor, with the condition becoming more common as people grow older. Genetics: Family history can increase susceptibility to AMD. Environmental factors: Smoking, exposure to ultraviolet light, and poor diet may contribute to the development of AMD. Cardiovascular health: Conditions like hypertension and high cholesterol levels can be linked to AMD risk. Oxidative stress: Damage from free radicals may harm the retinal cells over time.
Key Symptoms: Gradual loss of central vision, which makes it difficult to see fine details. Dark or blurry areas in the central vision Changes in color perception, such as duller colors Difficulty reading or recognizing faces Slow progression with symptoms developing over months or years Usually no pain or discomfort associated with the condition
Diagnostic & Treatment
Diagnosis Path: Amsler grid test: A simple chart to identify visual distortions or scotomas (blind spots). Fundus examination: Using an ophthalmoscope to examine the retina for characteristic signs of AMD. Optical coherence tomography (OCT): An imaging technique that provides detailed cross-sectional images of the retina. Fundus photography: Captures detailed color images of the retina for documentation and monitoring. Fluorescein angiography (less commonly used in dry AMD): To rule out or confirm neovascular (wet) AMD.
Treatment Protocols: Lifestyle modifications: Adopting a diet rich in green leafy vegetables, fish, and antioxidants. Nutritional supplements: High-dose formulations containing vitamins C and E, zinc, copper, lutein, and zeaxanthin may help reduce the risk of progression in some cases. Smoking cessation: Quitting smoking is vital to reduce further eye damage. Regular monitoring: Routine eye exams enable early detection of changes and progression. Low vision aids: Devices such as magnifiers can assist with daily activities as vision declines. Research and emerging therapies: Ongoing studies aim to find targeted treatments for dry AMD.
Clinical Advice & FAQs
Billing Guidance
Is H35.319 a billable ICD-10 code?
Yes, H35.319 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.319?
Clinical documentation must specify the nature of Nonexudative age-related macular degeneration, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference